Efficacy and safety of PD‐1/PD‐L1 inhibitor plus chemotherapy versus chemotherapy alone as first‐line treatment for extensive‐stage small cell lung cancer: A systematic review and meta‐analysis

BACKGROUND: Immunotherapy has afforded new treatment options for extensive small cell lung cancer (ES‐SCLC). However, reports on the effectiveness of immune checkpoint inhibitors (ICIs) combined with chemotherapy on survival in ES‐SCLC patients are inconsistent. Therefore, we conducted a meta‐analys...

Descripción completa

Detalles Bibliográficos
Autores principales: Zhang, Shuang, Li, Shuang, Cheng, Ying
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley & Sons Australia, Ltd 2020
Materias:
Original Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7705912/
https://www.ncbi.nlm.nih.gov/pubmed/33058504
http://dx.doi.org/10.1111/1759-7714.13698

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7705912/
https://www.ncbi.nlm.nih.gov/pubmed/33058504
http://dx.doi.org/10.1111/1759-7714.13698

Ejemplares similares